August 8th 2025
Here, we bring you our top five recent articles covering multiple stories on adult-use cannabis sales in Delaware, the top compliance issues in 2025, and research on how medical cannabis affects healthcare utilization by chronic pain patients.
One Case Study Shows How a Woman in the UK Reduced her Prescription Pain Medication With Cannabis
March 30th 2023A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.
Chronic Pain Research Endeavors: How an App and University Are Presenting Real-World Patient Data
September 23rd 2022One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.